• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EQ-5D-5L 值集研究的样本量确定

Sample size determination for EQ-5D-5L value set studies.

作者信息

Gandhi Mihir, Xu Ying, Luo Nan, Cheung Yin Bun

机构信息

Department of Biostatistics, Singapore Clinical Research Institute, #02-01, Nanos, 31 Biopolis Way, Singapore, Singapore.

Centre for Quantitative Medicine, Duke-NUS Medical School Level 6, Academia, 20 College Road, Singapore, Singapore.

出版信息

Qual Life Res. 2017 Dec;26(12):3365-3376. doi: 10.1007/s11136-017-1685-3. Epub 2017 Aug 19.

DOI:10.1007/s11136-017-1685-3
PMID:28825183
Abstract

PURPOSE

The EuroQol 5-Dimension (EQ-5D) is a widely used health status instrument for cost-utility analysis of healthcare interventions. Recently, its 5-Level version (EQ-5D-5L) and a protocol for conducting valuation of its health states were developed. We propose four approaches for estimating the sample size for EQ-5D-5L valuation according to the standardized procedures of the protocol.

METHODS

The first approach is for estimating mean health state utility values with a desired precision level using a regression model. The second approach, empirical in nature, determines a sample size based on mean absolute error in predicting health state values using a large-scale reference study. The last two approaches are for assessing the significance of regression coefficients of health state descriptors and to estimate the regression coefficients with a desired precision for predicting health state utility values.

RESULTS

Using data from a Singaporean study, we estimated parameters that are useful for sample size determination, including the design effect. Each of the approaches was illustrated with examples and pragmatic recommendations were provided.

CONCLUSIONS

Capitalizing on the EQ-5D-5L valuation protocol, we proposed four sample size estimation approaches which can help to decide an appropriate sample size for a value set study.

摘要

目的

欧洲五维健康量表(EQ - 5D)是一种广泛用于医疗保健干预措施成本效用分析的健康状况评估工具。最近,其五级版本(EQ - 5D - 5L)及其健康状态估值方案已制定出来。我们根据该方案的标准化程序,提出了四种估计EQ - 5D - 5L估值样本量的方法。

方法

第一种方法是使用回归模型,在期望的精度水平下估计平均健康状态效用值。第二种方法本质上是经验性的,基于大规模参考研究中预测健康状态值的平均绝对误差来确定样本量。最后两种方法用于评估健康状态描述符回归系数的显著性,并以期望的精度估计用于预测健康状态效用值的回归系数。

结果

利用一项新加坡研究的数据,我们估计了对样本量确定有用的参数,包括设计效应。每种方法都通过实例进行了说明,并给出了实用的建议。

结论

利用EQ - 5D - 5L估值方案,我们提出了四种样本量估计方法,这些方法有助于为价值集研究确定合适的样本量。

相似文献

1
Sample size determination for EQ-5D-5L value set studies.EQ-5D-5L 值集研究的样本量确定
Qual Life Res. 2017 Dec;26(12):3365-3376. doi: 10.1007/s11136-017-1685-3. Epub 2017 Aug 19.
2
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.一种用于获取健康状态偏好的混合建模方法:葡萄牙 EQ-5D-5L 值集。
Qual Life Res. 2019 Dec;28(12):3163-3175. doi: 10.1007/s11136-019-02226-5. Epub 2019 Jun 14.
3
3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set.迈向完美健康的 3125 步:开发 EQ-5D-5L 值集的非参数方法。
Qual Life Res. 2020 Nov;29(11):3109-3118. doi: 10.1007/s11136-020-02589-0. Epub 2020 Jul 23.
4
Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.健康状态抽样方法对 EQ-5D-5L 价值模型预测的影响:小样本设计即可满足要求。
Value Health. 2019 Jan;22(1):38-44. doi: 10.1016/j.jval.2018.06.015. Epub 2018 Jul 31.
5
Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.少即是多:EQ-5D-5L健康状态值简化非线性回归模型规范的交叉验证测试
Value Health. 2017 Jul-Aug;20(7):945-952. doi: 10.1016/j.jval.2017.03.013. Epub 2017 May 9.
6
Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review.方法学相似性和 EQ-5D-5L 值集研究的变化:系统评价。
J Med Econ. 2022 Jan-Dec;25(1):571-582. doi: 10.1080/13696998.2022.2066441.
7
Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease.基于心脏病患者偏好的 5 级 EQ-5D(EQ-5D-5L)值调查。
Value Health. 2022 Mar;25(3):451-460. doi: 10.1016/j.jval.2021.09.010. Epub 2021 Nov 25.
8
Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.测试替代回归模型以预测效用值:将 QLQ-C30 映射到 EQ-5D-5L 和 SF-6D 上。
Qual Life Res. 2018 Nov;27(11):2823-2839. doi: 10.1007/s11136-018-1981-6. Epub 2018 Sep 1.
9
Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study.评估欧洲质量生活五维度量表价值评估技术(EQ-VT)设计以生成国家价值集:使用扩展设计(DEVINE)研究开发印度 EQ-5D 价值集的经验教训。
Med Decis Making. 2023 Aug;43(6):692-703. doi: 10.1177/0272989X231180134. Epub 2023 Jul 22.
10
Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.评估研究中引入排序任务是否能提高数据质量并减少不一致性?以EQ-5D-5L为例。
Value Health. 2016 Jun;19(4):478-86. doi: 10.1016/j.jval.2016.02.002. Epub 2016 Mar 31.

引用本文的文献

1
A systematic review of condition-specific preference-based measures used in young people and their valuation methods.对年轻人使用的特定疾病偏好性测量方法及其评估方法的系统评价。
J Patient Rep Outcomes. 2024 Dec 19;8(1):151. doi: 10.1186/s41687-024-00826-5.
2
Valuation of EQ-5D-5L health states from cancer patients' perspective: a feasibility study.癌症患者视角下 EQ-5D-5L 健康状态的评估:一项可行性研究。
Eur J Health Econ. 2024 Aug;25(6):915-924. doi: 10.1007/s10198-023-01635-1. Epub 2023 Oct 14.
3
The Online Elicitation of Personal Utility Functions (OPUF) tool: a new method for valuing health states.

本文引用的文献

1
Employing quality control and feedback to the EQ-5D-5L valuation protocol to improve the quality of data collection.采用质量控制和对EQ-5D-5L评估协议的反馈来提高数据收集的质量。
Qual Life Res. 2017 May;26(5):1197-1208. doi: 10.1007/s11136-016-1445-9. Epub 2016 Oct 31.
2
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes.欧洲五维度健康量表健康结果时间权衡估值协议
Pharmacoeconomics. 2016 Oct;34(10):993-1004. doi: 10.1007/s40273-016-0404-1.
3
The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.
在线个人效用函数诱导(OPUF)工具:一种评估健康状态的新方法。
Wellcome Open Res. 2022 Jan 14;7:14. doi: 10.12688/wellcomeopenres.17518.1. eCollection 2022.
4
Sample Size and Model Prediction Accuracy in EQ-5D-5L Valuations Studies: Expected Out-of-Sample Accuracy Based on Resampling with Different Sample Sizes and Alternative Model Specifications.EQ-5D-5L评估研究中的样本量与模型预测准确性:基于不同样本量重采样和替代模型规格的预期样本外准确性
MDM Policy Pract. 2022 Mar 7;7(1):23814683221083839. doi: 10.1177/23814683221083839. eCollection 2022 Jan-Jun.
5
Health-related quality of life among COVID-19 individuals: A cross-sectional study in Tamil Nadu, India.新冠病毒感染者的健康相关生活质量:印度泰米尔纳德邦的一项横断面研究。
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100943. doi: 10.1016/j.cegh.2021.100943. Epub 2022 Jan 3.
6
How is quality of life defined and assessed in published research?发表的研究中如何定义和评估生活质量?
Qual Life Res. 2021 Aug;30(8):2109-2121. doi: 10.1007/s11136-021-02826-0. Epub 2021 Apr 1.
7
Cultural Values: Can They Explain Differences in Health Utilities between Countries?文化价值观:它们能否解释国家间健康效用的差异?
Med Decis Making. 2019 Jul;39(5):605-616. doi: 10.1177/0272989X19841587. Epub 2019 Jul 1.
慢性阻塞性肺疾病中的EQ-5D-5L健康状况问卷:效度、反应度和最小重要差异
Thorax. 2016 Jun;71(6):493-500. doi: 10.1136/thoraxjnl-2015-207782. Epub 2016 Mar 30.
4
A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.制定新的国际 EQ-5D-5L 估值议定书的方法学研究方案。
Value Health. 2014 Jun;17(4):445-53. doi: 10.1016/j.jval.2014.04.002.
5
The minimum clinically important difference for EQ-5D index: a critical review.EQ-5D指数的最小临床重要差异:一项批判性综述。
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33. doi: 10.1586/14737167.2014.894462.
6
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.使用通用和特定疾病健康相关生活质量测量指标进行 NICE 决策制定:系统评价、统计建模和调查。
Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090.
7
Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.新加坡EQ-5D-3L健康状态的估值:80种经验观察到的健康状态的时间权衡价值建模
Pharmacoeconomics. 2014 May;32(5):495-507. doi: 10.1007/s40273-014-0142-1.
8
The development of new research methods for the valuation of EQ-5D-5L.用于评估EQ-5D-5L的新研究方法的发展
Eur J Health Econ. 2013 Jul;14 Suppl 1(Suppl 1):S1-3. doi: 10.1007/s10198-013-0502-3.
9
Assessing potential sources of clustering in individually randomised trials.评估个体随机试验中聚集现象的潜在来源。
BMC Med Res Methodol. 2013 Apr 16;13:58. doi: 10.1186/1471-2288-13-58.
10
Valuing EQ-5D using time trade-off in France.使用时间权衡法在法国评估 EQ-5D 量表。
Eur J Health Econ. 2013 Feb;14(1):57-66. doi: 10.1007/s10198-011-0351-x. Epub 2011 Sep 21.